Labad, Jesseca D.
HRN: 13-18-82 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/25/2025
AMPICILLIN 1GM (VIAL)
08/25/2025
08/26/2025
IV
2 Grams
Q6
PPROM
Checking Initial Appropriateness
08/26/2025
AMPICILLIN 1GM (VIAL)
08/26/2025
08/27/2025
IV
1gm
Q6hr X 2 Doses
Sp PLTCS
Checking Initial Appropriateness
08/26/2025
CO-AMOXICLAV 625MG (TAB)
08/26/2025
09/01/2025
ORAL
500mg
BID
Sp PLTCS
Checking Initial Appropriateness
08/28/2025
MUPIROCIN 2%, 15G (TUBE)
08/28/2025
08/28/2025
TOPICAL
1ml
OD
SP LTCS
Checking Initial Appropriateness